Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?

被引:65
作者
Ruan, Wenjing [1 ]
Lai, Maode [1 ]
机构
[1] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310058, Zhejiang, Peoples R China
关键词
Insulin resistance; Obesity; Diabetes; Cardiovascular risk; CARDIOVASCULAR-DISEASE MORTALITY; IMPAIRED GLUCOSE-HOMEOSTASIS; CORONARY-HEART-DISEASE; I IGF-I; TRANSGENIC MICE; DIABETES-MELLITUS; RESISTANCE SYNDROME; CIRCULATING LEVELS; OBESE CHILDREN; ELDERLY-MEN;
D O I
10.1007/s00592-009-0142-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-like growth factor (IGF) binding proteins (IGFBPs) moved on to contain both IGF high- and low-affinity binders, exerting mitogenic and metabolic actions through its complex interplay between IGF/insulin and its IGF/insulin-independent manner. Progress on the metabolic-related function of IGFBPs has been rapid in recent years. A wealth of studies in 3T3-L1 adipocytes and the transgenic mice models demonstrated that IGFBPs played important roles in the pathogenesis of obesity and insulin resistance. Studies conducted in humans demonstrated the close relation between IGFBPs and the components of the metabolic syndrome. Abnormal expression of IGFBP was detected in various states of the metabolic disorders, suggesting that it could be used as a convenient and sensitive marker of insulin resistance, identification of insulin-resistant individuals at high cardiovascular risk, and may be an earlier marker of the metabolic syndrome. These exciting findings bring us new insight into the elucidation of the metabolic syndrome, which may have important clinical implications.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 89 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]  
Alford F. P., 1999, Journal of Endocrinological Investigation, V22, P28
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]   The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity [J].
Attia, N ;
Tamborlane, WV ;
Heptulla, R ;
Maggs, D ;
Grozman, A ;
Sherwin, RS ;
Caprio, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1467-1471
[5]   Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents [J].
Bacha, Fida ;
Saad, Rola ;
Gungor, Neslihan ;
Arslanian, Silva A. .
DIABETES CARE, 2006, 29 (07) :1599-1604
[6]   INCREASED PROTEOLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3) IN NONINSULIN-DEPENDENT DIABETES-MELLITUS SERUM, WITH ELEVATION OF A 29-KILODALTON (KDA) GLYCOSYLATED IGFBP-3 FRAGMENT CONTAINED IN THE APPROXIMATELY 130-KDA TO 150-KDA TERNARY COMPLEX [J].
BANG, P ;
BRISMAR, K ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1119-1127
[7]   Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities [J].
Baxter, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (06) :E967-E976
[8]   EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEINS DURING ADIPOGENESIS [J].
BONEY, CM ;
MOATSSTAATS, BM ;
STILES, AD ;
DERCOLE, AJ .
ENDOCRINOLOGY, 1994, 135 (05) :1863-1868
[9]  
BONISCHNETZLER M, 1990, MOL ENDOCRINOL, V4, P1320
[10]   THE RELATIONSHIP BETWEEN CIRCULATING ANDROGENS, OBESITY, AND HYPERINSULINEMIA ON SERUM INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN THE POLYCYSTIC OVARIAN SYNDROME [J].
BUYALOS, RP ;
PEKONEN, F ;
HALME, JK ;
JUDD, HL ;
RUTANEN, EM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (03) :932-939